Rule 170 of the Drugs and Cosmetics Rules
On 27th August, 2024, the Supreme Court of India, while hearing the case against Patanjali Ayurved, pulled up the AYUSH Ministry for its July 1, 2024, notification asking state licensing authorities “not to initiate/take any action under” Rule 170 of the Drugs and Cosmetics Act, 1940.
What is Rule 170?
- Introduction Date: It was introduced in 2018 to govern the manufacture, storage, and sale of medicines in the country, “specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines”.
- Rationale: The rule was introduced after a parliamentary standing committee highlighted the problem of misleading claims, and the need for the ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
India Watch
- 1 SC Expands Prison Reforms Panel Role to Safeguard Rights of Disabled Prisoners
- 2 Government Brings SAF-Blended Aviation Fuel under ATF Control Order
- 3 FIU-India and SEBI Sign MoU to Combat Money Laundering and Financial Crimes
- 4 SC Warns States on Illegal Sand Mining in Chambal Sanctuary
- 5 Draft Sugarcane (Control) Order 2026
- 6 India’s Rural Models and Development Diplomacy
- 7 Highway Safety Recognised as Part of Right to Life: Supreme Court
- 8 Operational Guidelines for the Urban Challenge Fund (UCF)
- 9 9th Indian Ocean Conference
- 10 Odisha Becomes First State to Launch Marine Spatial Plan
